Eli Health Secures $12M Series A Funding to Revolutionize Women's Hormonal Health Monitoring

We're thrilled to announce that Eli Health has successfully raised $12,000,000 in our latest funding round—a pivotal milestone that reinforces our commitment to transforming women's health. At Eli Health, our mission is to improve lifelong well-being by continuously monitoring hormones in saliva, thus addressing the critical need for comprehensive hormonal insights. Hormones are central to overall health at every stage of life, and traditional testing methods merely offer infrequent snapshots that fall short in capturing day-to-day fluctuations. Our breakthrough technology, born from years of dedicated research and development, allows women to easily track their hormonal profiles through three simple steps at home. This continuous monitoring delivers personalized data that empowers users to make informed decisions in key areas such as menopause, fertility, contraception, and various endocrine conditions. The funds we raised will bolster further innovation in our at-home testing platform, expand our diagnostic capabilities, and accelerate our efforts to bridge longstanding gaps in hormonal data. This investment will also help us scale our operations, refine our technology, and foster collaborations with leading healthcare experts to further validate and optimize our approach. We believe that by providing timely, actionable insights, we can revolutionize how women manage their overall health—from puberty through menopause and beyond—ultimately leading to improved quality of life. As we celebrate this exciting chapter, we’re also expanding our team. If you’re passionate about making a difference in the lives of countless women and want to join our groundbreaking mission, please visit bit.ly/eli-careers or reach out to us at hello@eli.health.